Oncodesign Precision Medicine Opm SA ALOPM.PA
€0.34
Last Updated: Jun 23, 12:00 AM·XPAR
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
ALOPM.PA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 25, 2025
Report Source: 2024 Annual Report
Oncodesign Precision Medicine Opm SA. Stock Analysis ALOPM.PA
France Health Care Nano Cap Report: Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company employs 13 full-time employees The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.
Read More Oncodesign Precision Medicine Opm SA (ALOPM.PA) Chart
Key Statistics of Oncodesign Precision Medicine Opm SA (ALOPM.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€0.34Volume
1.00P/E Ratio (TTM)
-52 Week Range
Market Cap
8.69MAvg. Volume
17.83KDividend Yield
-Financial Metrics & Statements of Oncodesign Precision Medicine Opm SA (ALOPM.PA)
FAQ's for Oncodesign Precision Medicine Opm SA (ALOPM.PA)
- According to Musaffa’s Shariah screening methodology, Oncodesign Precision Medicine Opm SA (ALOPM.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Oncodesign Precision Medicine Opm SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Oncodesign Precision Medicine Opm SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Oncodesign Precision Medicine Opm SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Oncodesign Precision Medicine Opm SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Oncodesign Precision Medicine Opm SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.